[1]
|
Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children. Allergy, 16, 178-222.
|
[2]
|
Dajani, A.S., Taubert, K.A., Gerber, M.A., et al. (1993) Diagnosis and Therapy of Kawasaki Disease in Children. Circulation, 87, 1776-1780. https://doi.org/10.1161/01.cir.87.5.1776
|
[3]
|
Yoon, K.L. (2015) Update of Genetic Susceptibility in Patients with Kawasaki Disease. Korean Journal of Pediatrics, 58, 84. https://doi.org/10.3345/kjp.2015.58.3.84
|
[4]
|
Shulman, S.T. and Rowley, A.H. (2015) Kawasaki Disease: Insights into Pathogenesis and Approaches to Treatment. Nature Reviews Rheumatology, 11, 475-482. https://doi.org/10.1038/nrrheum.2015.54
|
[5]
|
Lehman, T.J., Allen, J.B., Plotz, P.H., et al. (1983) Polyarthritis in Rats Following the Systemic Injection of Lactobacillus Casei Cell Walls in Aqueous Suspension. Arthritis & Rheumatology, 26, 1259-1265.
https://doi.org/10.1002/art.1780261013
|
[6]
|
Utsinger, P.D. (1980) Systemic Immune Complex Disease Following Intestinal Bypass Surgery: Bypass Disease. Journal of the American Academy of Dermatology, 2, 488-495. https://doi.org/10.1016/S0190-9622(80)80149-6
|
[7]
|
Cromartie, W.J. and Craddock, J.G. (1966) Rheumatic-Like Cardiac Lesions in Mice. Science, 154, 285-287.
https://doi.org/10.1126/science.154.3746.285
|
[8]
|
Ohanian, S.H., Schwab, J.H. and Cromartie, W.J. (1969) Relation of Rheumatic-Like Cardiac Lesions of the Mouse to Localization of Group: A Streptococcal Cell Walls. The Journal of Experimental Medicine, 129, 37-49.
|
[9]
|
Lehman, T.J., Walker, S.M., Mahnovski, V., et al. (1985) Coronary Arteritis in Mice Following the Systemic Injection of Group B Lactobacillus Casei Cell Walls in Aqueous Suspension. Arthritis & Rheumatology, 28, 652-659.
https://doi.org/10.1002/art.1780280609
|
[10]
|
Lehman, T.J. and Mahnovski, V. (1988) Animal Models of Vasculitis. Lessons We Can Learn to Improve our Understanding of Kawasaki Disease. Rheumatic Diseases Clinics of North America, 14, 479-487.
|
[11]
|
Lehman, T.J. (1993) Can We Prevent Long Term Cardiac Damage in Kawasaki Disease? Lessons from Lactobacillus Casei Cell Wall-Induced Arteritis in Mice. Clinical and Experimental Rheumatology, 11, 3-6.
|
[12]
|
Rosenkranz, M.E., Schulte, D.J., Agle, LM., et al. (2005) TLR2 and MyD88 Contribute to Lactobacillus Casei Extract-Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease. Circulation, 112, 2966-2973.
|
[13]
|
Lee, Y., Schulte, D.J., Shimada, K., et al. (2012) Interleukin-1 Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease. Circulation, 125, 1542-1550.
https://doi.org/10.1161/CIRCULATIONAHA.111.072769
|
[14]
|
Lau, A.C., Duong, T.T., Ito, S., et al. (2009) Inhibition of Matrix Metalloproteinase-9 Activity Improves Coronary Outcome in an Animal Model of Kawasaki Disease. Clinical & Experimental Immunology, 157, 300-309.
https://doi.org/10.1111/j.1365-2249.2009.03949.x
|
[15]
|
Yuen, J.S., Duong, T.T. and Yeung, R.S. (2006) TNF-Alpha Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease. The Journal of Immunology, 176, 6294-6301.
|
[16]
|
Lin, I., Sheen, J., Tain, Y., et al. (2014) Vascular Endothelial Growth Factor: A in Lactobacillus Casei Cell Wall Extract-Induced Coronary Arteritis of a Murine Model. Circulation Journal, 78, 752-762.
|
[17]
|
Lin, I.C., Kuo, H.C., Lin, Y.J., et al. (2012) Augmented TLR2 Expression on Monocytes in Both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis. PLOS ONE, 7, Article ID: 38635.
https://doi.org/10.1371/journal.pone.0038635
|
[18]
|
Murata, H. (1978) Experimental Arteritis on Murine with Candida—In Relation to Arteritis in MCLS. Kansenshogaku Zasshi, 52, 331-337. https://doi.org/10.11150/kansenshogakuzasshi1970.52.331
|
[19]
|
Murata, H. (1979) Experimental Candida-Induced Arteritis in Mice. Relation to Arteritis in the Mucocutaneous Lymph Node Syndrome. Microbiology and Immunology, 23, 825-831.
|
[20]
|
Murata, H. and Naoe, S. (1987) Experimental Candida-Induced Arteritis in Mice-Relation to Arteritis in Kawasaki Disease. Progress in Clinical and Biological Research, 250, 523.
|
[21]
|
Takahashi, K., Oharaseki, T., Wakayama, M., et al. (2004) Histopathological Features of Murine Systemic Vasculitis Caused by Candida Albicans Extract? An Animal Model of Kawasaki Disease. Inflammation Research, 53, 72-77.
|
[22]
|
Oharaseki, T., Kameoka, Y., Kura, F., et al. (2005) Susceptibility Loci to Coronary Arteritis in Animal Model of Kawasaki Disease Induced with Candida Albicans-Derived Substances. Microbiology and Immunology, 49, 181-189.
|
[23]
|
Onouchi, Z., Ikuta, K., Nagamatsu, K., et al. (1995) Coronary Artery Aneurysms Develop in Weanling Rabbits with Serum Sickness but Not in Mature Rabbits. An Experimental Model for Kawasaki Disease in Humans. Angiology, 46, 679-687. https://doi.org/10.1177/000331979504600806
|
[24]
|
韦卫中, 陈绍军, 王宏伟, 等. 免疫性血管炎致冠状动脉损伤的实验研究[J]. 华中科技大学学报(医学版), 2004, 33(1): 41-44.
|
[25]
|
Dou, J., Li, H., Sun, L., et al. (2013) Histopathological and Ultrastructural Examinations of Rabbit Coronary Artery Vasculitis Caused by Bovine Serum Albumin: An Animal Model of Kawasaki Disease. Ultrastructural Pathology, 37, 139-145. https://doi.org/10.3109/01913123.2012.750409
|
[26]
|
Philip, S., Lee, W., Liu, S., et al. (2004) A Swine Model of Horse Serum-Induced Coronary Vasculitis: An Implication for Kawasaki Disease. Pediatric Research, 55, 211-219. https://doi.org/10.1203/01.PDR.0000104151.26375.E5
|
[27]
|
Philip, S., Lee, W., Wu, M., et al. (2014) Histopathological Evaluation of Horse Serum-Induced Immune Complex Vasculitis in Swine: Implication to Coronary Artery Lesions in Kawasaki Disease. Pediatrics & Neonatology, 55, 297- 305. https://doi.org/10.1016/j.pedneo.2013.10.012
|
[28]
|
Burns, J.C., Felsburg, P. J., Wilson, H., et al. (1991) Canine Pain Syndrome Is a Model for the Study of Kawasaki Disease. Perspectives in Biology and Medicine, 35, 68-73. https://doi.org/10.1353/pbm.1991.0040
|
[29]
|
Felsburg, P.J., HogenEsch, H., Somberg, R.L., et al. (1992) Immunologic Abnormalities in Canine Juvenile Polyarteritis Syndrome: A Naturally Occurring Animal Model of Kawasaki Disease. Clinical Immunology and Immunopathology, 65, 110-118. https://doi.org/10.1016/0090-1229(92)90213-8
|
[30]
|
Schulte, D.J., Yilmaz, A., Shimada, K., et al. (2009) Involvement of Innate and Adaptive Immunity in a Murine Model of Coronary Arteritis Mimicking Kawasaki Disease. The Journal of Immunology, 183, 5311-5318.
|
[31]
|
Orenstein, J.M., Shulman, S.T., Fox, L.M., et al. (2012) Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study. PLOS ONE, 7, Article ID: 38998.
https://doi.org/10.1371/journal.pone.0038998
|
[32]
|
Sahr, A., Former, S., Hildebrand, D., et al. (2015) T-Cell Activation or Tolerization: The Yin and Yang of Bacterial Superantigens. Frontiers in Microbiology, 6, 1153. https://doi.org/10.3389/fmicb.2015.01153
|
[33]
|
Abe, J., Kotzin, B.L., Jujo, K., et al. (1992) Selective Expansion of T Cells Expressing T-Cell Receptor Variable Regions V Beta 2 and V Beta 8 in Kawasaki Disease. Proceedings of the National Academy of Sciences, 89, 4066-4070.
|
[34]
|
Abe, J., Kotzin, B.L., Meissner, C., et al. (1993) Characterization of T-Cell Repertoire Changes in Acute Kawasaki Disease. Journal of Experimental Medicine, 177, 791-796. https://doi.org/10.1084/jem.177.3.791
|
[35]
|
Duong, T.T., Silverman, E.D., Bissessar, M.V., et al. (2003) Super Antigenic Activity Is Responsible for Induction of Coronary Arteritis in Mice: An Animal Model of Kawasaki Disease. International Immunology, 15, 79-89.
https://doi.org/10.1093/intimm/dxg007
|
[36]
|
Kalliolias, G.D. and Ivashkiv, L.B. (2016) TNF Biology, Pathogenic Mechanisms and Emerging Therapeutic Strategies. Nature Reviews Rheumatology, 12, 49-62. https://doi.org/10.1038/nrrheum.2015.169
|
[37]
|
Chien, Y.H., Chang, K., Yang, Y.H., et al. (2003) Association between Levels of TNF-Alpha and TNF-Alpha Promoter-308 A/A Polymorphism in Children with Kawasaki Disease. Journal of the Formosan Medical Association, 102, 147-150.
|
[38]
|
Ma, L. and Du, Z.D. (2016) Advances in the Pathogenesis of Vascular Endothelial Cells Injury in Kawasaki Disease. Chinese Journal of Pediatrics, 54, 158-160.
|
[39]
|
Sakata, K., Hamaoka, K., Ozawa, S., et al. (2010) Matrix Metalloproteinase-9 in Vascular Lesions and Endothelial Regulation in Kawasaki Disease. Official Journal of the Japanese Circulation Society, 74, 1670-1675.
https://doi.org/10.1253/circj.CJ-09-0980
|
[40]
|
张艳兰, 杜忠东, 杨海明, 等. 川崎病小鼠肿瘤坏死因子α/核因子κB/基质金属蛋白酶-9通路研究[J]. 中国循证儿科杂志, 2014, 9(1), 59-63.
|
[41]
|
Oharaseki, T., Yokouchi, Y., Yamada, H., et al. (2013) The Role of TNF-α in a Murine Model of Kawasaki Disease Arteritis Induced with a Candida Albicans Cell Wall Polysaccharide. Modern Rheumatology, 24, 120-128.
https://doi.org/10.3109/14397595.2013.854061
|
[42]
|
Jiang, C., Fang, X., Jiang, Y., et al. (2016) TNF-α Induces Vascular Endothelial Cells Apoptosis through Overexpressing Pregnancy Induced Noncoding RNA in Kawasaki Disease Model. The International Journal of Biochemistry & Cell Biology, 72, 118-124. https://doi.org/10.1016/j.biocel.2016.01.011
|
[43]
|
Lee, Y., Wakita, D., Dagvadorj, J., et al. (2015) IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model Significance. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 2605-2616.
|
[44]
|
Wakita, D., Kurashima, Y., Crother, T.R., et al. (2016) Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology, 36, 886-897.
https://doi.org/10.1161/ATVBAHA.115.307072
|
[45]
|
Miyamoto, K., Yamazaki, Y., Okamoto, K., et al. (2013) Kawasaki Disease: Relationship between Acute Surgical Abdomen and Cytokine Profiles. The Pediatric Infectious Disease Journal, 32, 1299.
https://doi.org/10.1097/INF.0b013e31829ece3d
|
[46]
|
Fury, W., Tremoulet, A.H., Watson, V.E., et al. (2010) Transcript Abundance Patterns in Kawasaki Disease Patients with Intravenous Immunoglobulin Resistance. Human Immunology, 71, 865-873.
https://doi.org/10.1016/j.humimm.2010.06.008
|
[47]
|
Chan, W.C., Duong, T.T. and Yeung, R.S.M. (2004) Presence of IFN-Does Not Indicate Its Necessity for Induction of Coronary Arteritis in an Animal Model of Kawasaki Disease. The Journal of Immunology, 173, 3492-3503.
https://doi.org/10.4049/jimmunol.173.5.3492
|
[48]
|
Muvva, C., Patra, S. and Venkatesan, S. (2016) MMPI: A Wide Range of Available Compounds of Matrix Metalloproteinase Inhibitors. PLOS ONE, 11, Article ID: 159321.
|
[49]
|
Kurzepa, J., El-Demerdash, F.M. and Castellazzi, M. (2016) Matrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology. Disease Markers, 2016, Article ID: 9275204.
|
[50]
|
Tscheuschler, A., Meffert, P., Beyersdorf, F., et al. (2016) MMP-2 Isoforms in Aortic Tissue and Serum of Patients with Ascending Aortic Aneurysms and Aortic Root Aneurysms. PLOS ONE, 11, Article ID: 164308.
https://doi.org/10.1371/journal.pone.0164308
|
[51]
|
Lau, A.C., Rosenberg, H., Duong, T.T., et al. (2007) Elastolytic Matrix Metalloproteinases and Coronary Outcome in Children with Kawasaki Disease. Pediatric Research, 61, 710-715. https://doi.org/10.1203/pdr.0b013e318053418b
|
[52]
|
Lau, A.C., Duong, T.T., Ito, S., et al. (2008) Matrix Metalloproteinase 9 Activity Leads to Elastin Breakdown in an Animal Model of Kawasaki Disease. Arthritis & Rheumatism, 58, 854-863. https://doi.org/10.1002/art.23225
|
[53]
|
Gavin, P.J., Crawford, S.E., Shulman, S.T., et al. (2003) Systemic Arterial Expression of Matrix Metalloproteinases 2 and 9 in Acute Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 576-581.
|
[54]
|
Korematsu, S., Ohta, Y., Tamai, N., et al. (2012) Cell Distribution Differences of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Kawasaki Disease. The Pediatric Infectious Disease Journal, 31, 973-974. https://doi.org/10.1097/INF.0b013e31825ba6b3
|
[55]
|
Szatmary, Z. (2012) Molecular Biology of Toll-Like Receptors. General Physiology and Biophysics, 31, 357-366.
|
[56]
|
Duffy, L. and O'Reilly, S.C. (2016) Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases: Recent and Emerging Translational Developments. ImmunoTargets and Therapy, 5, 69-80. https://doi.org/10.2147/ITT.S89795
|
[57]
|
Joosten, L.A., Abdollahi-Roodsaz, S., Dinarello, C.A., et al. (2016) Toll-Like Receptors and Chronic Inflammation in Rheumatic Diseases: New Developments. Nature Reviews Rheumatology, 12, 344-357.
|
[58]
|
Lin, J., Kakkar, V. and Lu, X. (2016) Essential Roles of Toll-Like Receptors in Atherosclerosis. Current Medicinal Chemistry, 23, 431-454. https://doi.org/10.2174/0929867323666151207111408
|
[59]
|
Krogmann, A.O., Lusebrink, E., Steinmetz, M., et al. (2016) Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CPG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice. PLOS ONE, 11, Article ID: 146326. https://doi.org/10.1371/journal.pone.0146326
|
[60]
|
Michelsen, K.S., Wong, M.H., Shah, P.K., et al. (2004) Lack Of Toll-Like Receptor 4 or Myeloid Differentiation Factor 88 Reduces Atherosclerosis and Alters Plaque Phenotype in Mice Deficient in Apolipoprotein E. Proceedings of the National Academy of Sciences, 101, 10679-10684. https://doi.org/10.1073/pnas.0403249101
|
[61]
|
Lu, Z., Zhang, X., Li, Y., et al. (2013) TLR4 Antagonist Reduces Early-Stage Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice. Journal of Endocrinology, 216, 61-71. https://doi.org/10.1530/JOE-12-0338
|
[62]
|
Alvira, C.M., Guignabert, C., Kim, Y., et al. (2011) Inhibition of Transforming Growth Factor β Worsens Elastin Degradation in a Murine Model of Kawasaki Disease. The American Journal of Pathology, 178, 1210-1220.
https://doi.org/10.1016/j.ajpath.2010.11.054
|
[63]
|
Lin, I., Suen, J., Huang, S., et al. (2013) Dectin-1/Syk Signaling Is Involved in Lactobacillus Casei Cell Wall Extract-Induced Mouse Model of Kawasaki Disease. Immunobiology, 218, 201-212.
|
[64]
|
Hamaoka-Okamoto, A., Suzuki, C., Yahata, T., et al. (2014) The Involvement of the Vasa Vasorum in the Development of Vasculitis in Animal Model of Kawasaki Disease. Pediatric Rheumatology Online Journal, 12, 12.
|
[65]
|
Nakamura, A., Okigaki, M., Miura, N., et al. (2014) Involvement of Mannose-Binding Lectin in the Pathogenesis of Kawasaki Disease-Like Murine Vasculitis. Clinical Immunology, 153, 64-72.
https://doi.org/10.1016/j.clim.2014.03.019
|
[66]
|
Yoshikane, Y., Koga, M., Imanaka-Yoshida, K., et al. (2015) JNK Is Critical for the Development of Candida Albicans-Induced Vascular Lesions in a Mouse Model of Kawasaki Disease. Cardiovascular Pathology, 24, 33-40.
https://doi.org/10.1016/j.carpath.2014.08.005
|
[67]
|
Chen, S., Lee, Y., Crother, T.R., et al. (2012) Marked Acceleration of Atherosclerosis after Lactobacillus Casei-Induced Coronary Arteritis in a Mouse Model of Kawasaki Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 60-71. https://doi.org/10.1161/ATVBAHA.112.249417
|
[68]
|
Stock, A.T., Hansen, J.A., Sleeman, M.A., et al. (2016) GM-CSF Primes Cardiac Inflammation in a Mouse Model of Kawasaki Disease. The Journal of Experimental Medicine, 213, 1983-1998. https://doi.org/10.1084/jem.20151853
|
[69]
|
Takahashi, K., Oharaseki, T., Yokouchi, Y., et al. (2010) Administration of Human Immunoglobulin Suppresses Development of Murine Systemic Vasculitis Induced with Candida Albicans Water-Soluble Fraction: An Animal Model of Kawasaki Disease. Modern Rheumatology, 20, 160-167. https://doi.org/10.3109/s10165-009-0250-5
|